G1 Execution Services, LLC

All filings by G1 Execution Services, LLC on record concern Achillion Pharmaceuticals Inc. The record holds 2 filings, all for trades on 28 January 2020.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 30 January 2020, the filings show a transaction worth €62k in Achillion Pharmaceuticals Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.